-
DiscoverySaving tumor suppressors from the shredder
Novartis opens up a path of research to protect proteins that guard against cancer.
Discovery -
DiscoveryWomen in Science: Medy Attalla
Discovery -
DiscoveryThe specter of malaria that resists treatment
Great progress has been made against malaria, but signs of resistance are becoming a rising concern
Discovery -
DiscoveryLoss of friend to liver cancer sharpens focus on experimental therapy
A Novartis experimental drug in clinical trial aims to block liver cancer growth
Discovery -
DiscoveryWomen in Science: Annie Martin
Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.
Discovery -
From Our LabsCould digital technology drive clinical research in Africa?
Novel digital platform for clinical trial data collection could help facilitate much-needed biomedical research in lower-income countries.
From Our Labs -
DiscoveryEyewitness to a healer pursues new treatments for patients
Inspired by her mother, Vicky Qi leads drug discovery teams.
Discovery -
DiscoveryStriving to vanquish leukemia
Combination of two compounds shows promise in the lab
Discovery -
Patient PerspectivesInside a cancer diagnosis
Melanoma survivor T.J. Sharpe shares key insights about the cancer diagnosis experience.
Patient Perspectives -
Patient PerspectivesRare Every Day: Experiences, challenges and victories of the rare disease community
Patient Perspectives -
Patient PerspectivesMeet T.J. Sharpe
Meet Melanoma survivor TJ Sharpe in the first installment of his new blog series on Novartis.com.
Patient Perspectives -
From Our LabsCountering the genome reprogramming of cancer cells
Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model
From Our Labs